Building on a history of immune response, oncologists today are excited about a new class of immunotherapies called immune checkpoint inhibitors that have significantly reduced the risk of recurrence for bladder cancer while also increasing the percentage of patients who see a complete response post-surgery. Help us extend these benefits to more patients.
Monthly donations help us plan and allocate resources effectively to advance research and save more lives.
I would like to create a card as part of my donation.
I want to receive the latest cancer immunotherapy news.
Find out if your employer will match your donation:
By clicking I agree to the terms & conditions
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442.Donations are tax-deductible to the fullest extent allowable under the law.